Search
for
Sort by
Research 511–540 of 528
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- The Sebaceous Gland - Friend or Foe?
- LB1048 Effectiveness of OR-101 in a murine model of atopic dermatitis
- A novel hairless highly immunodeficient mice model optimized for in vivo imaging
- Identification of potential key genes and pathways associated with the Pashmina fiber initiation using RNA-Seq and integrated bioinformatics analysis
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- Baricitinib in the Treatment of Frontal Fibrosing Alopecia: Mid Trial Update
- Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata
- Pharmacological activities of Abrus precatorius Linn.: A comprehensive review of its ethnomedicinal uses and phytochemical profile.
- Pharmacological activities of Abrus precatorius Linn.: A comprehensive review of its ethnomedicinal uses and phytochemical profile.
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- Efficacy and Safety of Ritlecitinib in Alopecia Areata: A Systematic Review and Meta-Analysis (Preprint)
- 056 IKZF1 and IKAROS overexpression contributes to the pathogenesis of alopecia areata
- A perspective on predictive markers of alopecia
- 865 Frontal fibrosing alopecia is associated with dysregulation of cholesterol biosynthesis pathways, fibrosis and mast cells
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Implication of microRNA regulation in para-phenylenediamine-induced cell death and senescence in normal human hair dermal papilla cells
- <div>Six years of the IP Indian Journal of Clinical and Experimental Dermatology (2019-2025):&nbsp;<span style="font-size: 1rem;">A bibliometric and thematic analysis</span></div>
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Under Development JAK Inhibitors for Dermatologic Diseases
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- JAK inhibitors in dermatology: The promise of a new drug class
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)